Shareholders in Alkermes have quelled a challenge from Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor, the Ireland-based drugmaker said.

Sarissa owns 8.45% of Alkermes, which is valued at $5.2 billion. This is the third time Sarissa has mounted a challenge. In 2021, Sarissa and Alkermes reached an agreement to add a new director.

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat ...

Days after shareholders of Amarin sided with activist investor Sarissa Capital, removing Chairman Per Wold-Olsen and adding seven new members to its board in a resounding vote, the troubled Irish ...

Sarissa believes Amarin leadership will continue to destroy shareholder value during this critical period; We cannot afford to maintain the status quo Sarissa has a stellar track record of success ...

(RTTNews) - Sarissa Capital Management LP said it plans to vote for the Alkermes (ALKS) slate of directors at the upcoming annual meeting. However, Sarissa noted that if its representative is not ...

ISS however did not back Sarissa's two other nominees, including the hedge fund's co-founder Alex Denner. Alkermes said Schlesinger, who has been nominated by Denner to sit on other boards ...

If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital Management, a Greenwich-based ...

Amarin (NASDAQ:AMRN) and Sarissa are engaged in a major proxy war, but win or lose, Amarin is in a poor position right now after those bright days before the Judge Du judgment that routed the stock.

NEW YORK, June 13 (Reuters) - Activist investor Sarissa Capital may have cleared a stumbling block in its push for board seats at Alkermes (ALKS.O), opens new tab when one of its candidates ...

Here’s why. Sarissa Capital finished the fourth quarter with just eight holdings, an average of $40.4 million per stock. Considering some billionaire investor hedge funds, that’s not a ...